Portal de Periódicos da CAPES

Consider TLR5 for new therapeutic development against COVID‐19

2020; Wiley; Volume: 92; Issue: 11 Linguagem: Inglês

10.1002/jmv.25997

1096-9071

Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, Garima Sharma, Sang‐Soo Lee, Govindasamy Agoramoorthy,

Immune Response and Inflammation

Journal of Medical VirologyVolume 92, Issue 11 p. 2314-2315 LETTER TO THE EDITOR Consider TLR5 for new therapeutic development against COVID-19 Chiranjib Chakraborty, Corresponding Author Chiranjib Chakraborty [email protected] orcid.org/0000-0002-3958-239X Department of Biotechnology, School of Life Science and Biotechnology, Adamas University, Kolkata, West Bengal, India Institute for Skeletal Ageing and Orthopedic Surgery, Hallym University Chuncheon sacred Heart Hospital, Chuncheon-si, Gangwon-do, Korea Correspondence Chiranjib Chakraborty, PhD, Department of Biotechnology, School of Life Science and Biotechnology, Adamas University, Barasat-Barrackpore, Rd, Jagannathpur, Kolkata, West Bengal 700126, India. Email: [email protected] Govindasamy Agoramoorthy, PhD, College of Pharmacy and Health Care, Tajen University, Yanpu, Pingtung 907, Taiwan, China. Email: [email protected]Search for more papers by this authorAshish Ranjan Sharma, Ashish Ranjan Sharma orcid.org/0000-0003-3973-6755 Institute for Skeletal Ageing and Orthopedic Surgery, Hallym University Chuncheon sacred Heart Hospital, Chuncheon-si, Gangwon-do, KoreaSearch for more papers by this authorManojit Bhattacharya, Manojit Bhattacharya orcid.org/0000-0001-9669-1835 Institute for Skeletal Ageing and Orthopedic Surgery, Hallym University Chuncheon sacred Heart Hospital, Chuncheon-si, Gangwon-do, KoreaSearch for more papers by this authorGarima Sharma, Garima Sharma orcid.org/0000-0003-1763-0730 Neuropsychopharmacology and Toxicology Program, College of Pharmacy, Kangwon National University, Chuncheon, Republic of KoreaSearch for more papers by this authorSang-Soo Lee, Sang-Soo Lee Institute for Skeletal Ageing and Orthopedic Surgery, Hallym University Chuncheon sacred Heart Hospital, Chuncheon-si, Gangwon-do, KoreaSearch for more papers by this authorGovindasamy Agoramoorthy, Corresponding Author Govindasamy Agoramoorthy [email protected] orcid.org/0000-0002-8936-6978 College of Pharmacy and Health Care, Tajen University, Taiwan, China Correspondence Chiranjib Chakraborty, PhD, Department of Biotechnology, School of Life Science and Biotechnology, Adamas University, Barasat-Barrackpore, Rd, Jagannathpur, Kolkata, West Bengal 700126, India. Email: [email protected] Govindasamy Agoramoorthy, PhD, College of Pharmacy and Health Care, Tajen University, Yanpu, Pingtung 907, Taiwan, China. Email: [email protected]Search for more papers by this author Chiranjib Chakraborty, Corresponding Author Chiranjib Chakraborty [email protected] orcid.org/0000-0002-3958-239X Department of Biotechnology, School of Life Science and Biotechnology, Adamas University, Kolkata, West Bengal, India Institute for Skeletal Ageing and Orthopedic Surgery, Hallym University Chuncheon sacred Heart Hospital, Chuncheon-si, Gangwon-do, Korea Correspondence Chiranjib Chakraborty, PhD, Department of Biotechnology, School of Life Science and Biotechnology, Adamas University, Barasat-Barrackpore, Rd, Jagannathpur, Kolkata, West Bengal 700126, India. Email: [email protected] Govindasamy Agoramoorthy, PhD, College of Pharmacy and Health Care, Tajen University, Yanpu, Pingtung 907, Taiwan, China. Email: [email protected]Search for more papers by this authorAshish Ranjan Sharma, Ashish Ranjan Sharma orcid.org/0000-0003-3973-6755 Institute for Skeletal Ageing and Orthopedic Surgery, Hallym University Chuncheon sacred Heart Hospital, Chuncheon-si, Gangwon-do, KoreaSearch for more papers by this authorManojit Bhattacharya, Manojit Bhattacharya orcid.org/0000-0001-9669-1835 Institute for Skeletal Ageing and Orthopedic Surgery, Hallym University Chuncheon sacred Heart Hospital, Chuncheon-si, Gangwon-do, KoreaSearch for more papers by this authorGarima Sharma, Garima Sharma orcid.org/0000-0003-1763-0730 Neuropsychopharmacology and Toxicology Program, College of Pharmacy, Kangwon National University, Chuncheon, Republic of KoreaSearch for more papers by this authorSang-Soo Lee, Sang-Soo Lee Institute for Skeletal Ageing and Orthopedic Surgery, Hallym University Chuncheon sacred Heart Hospital, Chuncheon-si, Gangwon-do, KoreaSearch for more papers by this authorGovindasamy Agoramoorthy, Corresponding Author Govindasamy Agoramoorthy [email protected] orcid.org/0000-0002-8936-6978 College of Pharmacy and Health Care, Tajen University, Taiwan, China Correspondence Chiranjib Chakraborty, PhD, Department of Biotechnology, School of Life Science and Biotechnology, Adamas University, Barasat-Barrackpore, Rd, Jagannathpur, Kolkata, West Bengal 700126, India. Email: [email protected] Govindasamy Agoramoorthy, PhD, College of Pharmacy and Health Care, Tajen University, Yanpu, Pingtung 907, Taiwan, China. Email: [email protected]Search for more papers by this author First published: 11 May 2020 https://doi.org/10.1002/jmv.25997Citations: 50Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookxLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Bhattacharya M, Sharma AR, Patra P, et al. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): immunoinformatics approach. J Med Virol. 2020; 92: 618-631. 10.1002/jmv.25736 CASPubMedWeb of Science®Google Scholar 2Yang J, Yan H. TLR5: beyond the recognition of flagellin. Cell Mol Immunol. 2017; 14(12): 1017-1019. 10.1038/cmi.2017.122 CASPubMedWeb of Science®Google Scholar 3Mifsud EJ, Tan AC-L, Jackson DC. TLR agonists as modulators of the innate immune response and their potential as agents against infectious disease. Front Immunol. 2014; 5: 79. 10.3389/fimmu.2014.00079 PubMedWeb of Science®Google Scholar 4Cao Y, Zhang E, Yang J, et al. Frontline science: nasal epithelial GM-CSF contributes to TLR5-mediated modulation of airway dendritic cells and subsequent IgA response. J Leukoc Biol. 2017; 102(3): 575-587. 10.1189/jlb.3HI0816-368RR CASPubMedWeb of Science®Google Scholar 5Song WS, Jeon YJ, Namgung B, Hong M, Yoon S-I. A conserved TLR5 binding and activation hot spot on flagellin. Sci Rep. 2017; 7(1): 1-11. PubMedWeb of Science®Google Scholar 6Song L, Xiong D, Kang X, et al. An avian influenza A (H7N9) virus vaccine candidate based on the fusion protein of hemagglutinin globular head and Salmonella typhimurium flagellin. BMC Biotechnol. 2015; 15(1): 79. 10.1186/s12896-015-0195-z PubMedWeb of Science®Google Scholar 7Georgel A-F, Cayet D, Pizzorno A, et al. Toll-like receptor 5 agonist flagellin reduces influenza A virus replication independently of type I interferon and interleukin 22 and improves antiviral efficacy of oseltamivir. Antiviral Res. 2019; 168: 28-35. 10.1016/j.antiviral.2019.05.002 CASPubMedWeb of Science®Google Scholar 8McDonald WF, Huleatt JW, Foellmer HG, et al. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity. J Infect Dis. 2007; 195(11): 1607-1617. 10.1086/517613 CASPubMedWeb of Science®Google Scholar 9Deere JD, Chang WLW, Castillo LD, et al. Utilizing a TLR5-adjuvanted cytomegalovirus as a lentiviral vaccine in the nonhuman primate model for AIDS. PLOS One. 2016; 11(5):e0155629. 10.1371/journal.pone.0155629 PubMedWeb of Science®Google Scholar 10Kim E, Erdos G, Huang S, et al. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development [published online ahead of print April 1, 2020]. EBioMedicine. 2020:102743. https://doi.org/10.1016/j.ebiom.2020.102743 10.1016/j.ebiom.2020.102743 PubMedWeb of Science®Google Scholar 11Mehta P, Mcauley D, Brown M, et al. Correspondence COVID-19: consider cytokine storm syndromes and. The Lancet.2020; 6736(20): 19-20. Google Scholar 12Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China [published online ahead of print March 12, 2020]. Clin Infect Dis. 2020. https://doi.org/10.1093/cid/ciaa248 10.1093/cid/ciaa248 Web of Science®Google Scholar 13Golonka RM, Saha P, Yeoh BS, et al. Harnessing innate immunity to eliminate SARS-CoV-2 and ameliorate COVID-19 disease. Physiol Genom. 2020; 52(5): 217-221. 10.1152/physiolgenomics.00033.2020 CASPubMedWeb of Science®Google Scholar Citing Literature Volume92, Issue11Special Issue on New coronavirus (2019‐nCoV or SARS‐CoV‐2) and the outbreak of the respiratory illness (COVID‐19): Part‐VIINovember 2020Pages 2314-2315 ReferencesRelatedInformation